Launches small satellites on its Electron rocket and builds spacecraft components.
$51.22close as of 2026-10-22
-15.4% over 1Y · 31.1 points behind the S&P 500
RKLBS&P 500 (SPY), rebased to RKLB's first close
“Can Rocket Lab deliver Neutron to the pad in late 2026 while turning its expanding spacecraft backlog into cash?”
Editorial note · updated 2026-10-02
The TenQ Radar
Rocket Lab in 36 checks
Rocket Lab on the TenQ Radar: value, growth, quality, health, shareholder returns and trend. The fuller the shape, the stronger the company. Behind each axis are six pass-or-fail checks from its filings, spelled out in the chapters below. Point at an axis to see them.
The business itself is the question here: 9 of 36 checks passed.
The Rocket Lab story
What drives Rocket Lab, what its price assumes and what could change the story, written from its own filings.
Spacecraft lead the business. Space Systems contributed $189 million of Rocket Lab’s $234 million revenue in the quarter to June 2026, making satellite hardware and manufacturing its largest business.
Neutron connects the ambitions. The planned medium-lift rocket is central to Rocket Lab’s constellation strategy and its $397 million Space Force award announced in August 2026, which includes options.
Financing changes the equation. Rocket Lab announced full financing for Iridium in September 2026 after raising approximately $1.944 billion through 29.3 million shares, replacing the bridge financing risk with dilution and permanent debt commitments.
Q2 '26 · quarter to 30 June 2026 · reported 10 August 2026 · Earnings release ↗
Revenue$234M+62%vs 2025+17%vs Q1
Earnings-$49M+$17Mvs 2025-$4Mvs Q1
Against its own guidance
This quarter●Met its guidance
Actual $234M
Guided $225M to $240M
Revenue came in inside the range it guided in May 2026.
Next quarter▲Guides 10% growth on this quarter
This quarter $234M
Guided $250M to $265M
Measured at the midpoint of its range. +66% on Q3 '25.
What the release says
Highlights
Rocket Lab reported record quarterly revenue of $234 million for Q2 2026, a 62% increase year-over-year and $34 million higher than the previous quarter, driven by strong demand across all business areas.
The company achieved a record backlog of $2.36 billion, up 137% year-over-year, and secured more than $437 million in new launch contracts during Q2 2026 and post-quarter signings, expanding its total launch backlog to over 90 launches.
Rocket Lab announced a landmark agreement to acquire Iridium Communications Inc., aiming to create a fully vertically-integrated space company capable of designing, building, launching, and operating its own constellations for global communications.
The company closed the acquisitions of Mynaric and Motiv, introduced the GHOST globally-deployable launch system with its first operational debut planned for Alaska in 2027, and achieved key milestones in the development of its Neutron medium-lift reusable rocket.
What management expects
For the third quarter of 2026, Rocket Lab expects revenue between $250 million and $265 million.
GAAP Gross Margins are expected to be between 29% and 31%, with Non-GAAP Gross Margins between 35% and 37%.
GAAP Operating Expenses are projected between $143 million and $149 million, Non-GAAP Operating Expenses between $121 million and $127 million, and an Adjusted EBITDA loss of between $17 million and $23 million.
Key risks
New The completion of the Iridium acquisition is subject to multiple conditions, including shareholder and regulatory approvals, and any failure or delay in satisfying these conditions could prevent or postpone the transaction, potentially affecting Rocket Lab's ability to realize expected benefits.
New Rocket Lab expects to incur or assume substantial additional indebtedness to finance the Iridium acquisition, which could increase financial risk, limit operational flexibility, and require significant cash flow for debt service, potentially impacting development and growth programs.
Rocket Lab's rapid growth and increasing organizational complexity may strain management and operational resources, and failure to manage this growth could harm its ability to execute its business plan and negatively impact results.
A significant portion of revenue and backlog is concentrated among a few major customers, and the loss, default, or financial difficulties of any of these customers could materially reduce future revenues and contracted backlog.
The company is highly dependent on government contracts, particularly with the U.S. government, and changes in government policies, funding levels, or contract terminations could adversely affect its business, financial condition, and cash flows.
Rocket Lab's operations rely on a limited number of key vendors and suppliers for critical products and services, and any disruption, delay, or price increase from these vendors could materially impair its ability to fulfill contracts and operate efficiently.
AI summary of the company's filings, every number checked against them · 8 October 2026 · Sources: earnings release, 10-K, 10-Q
Earnings alerts
An email when Rocket Lab reports, with its results and highlights. Free with a watchlist account.
I
Value
●●●●●●0/6
Expensive against its own history and its sector (judged on sales, as it is not yet profitable): the price asks a lot of the business.
-no history
39.8xown 5-year median 13.5x
-1.2%cash earned per $ of price
-whole-business multiple
Valuation history
Is RKLB's P/E, P/S or P/B high or low against its own past?
Year
P/E
P/S
P/B
2026
-
39.8462
8.7761
◌ 2026 = at the latest close (2026-10-22), over the trailing twelve months; earlier years are annual averages · the last point is at the latest close (2026-10-22); earlier quarters use that quarter's average price over the trailing twelve months to it
→At 39.8x sales, the market is paying +195% more than RKLB's own 5-year median of 13.5x. Expectations are elevated, so more has to go right to justify the price.
What this measures
What the market has paid for each dollar of earnings, sales or book value, every year, with today's multiple as the last point and the median drawn across.
What good looks like. There is no good level. What matters is the distance from the company's own history, and whether the business has changed enough to justify it.
If it rises or falls. A multiple above its own median means the market expects more than it used to, so more has to go right. Below the median means the opposite, and the question is whether the pessimism is deserved. A multiple can also fall because earnings rose, which is the good way.
Free cash flow yield
What is RKLB's free cash flow yield at today's price?
Period
FCF yield
2021
-0.0393
2022
-0.0523
2023
-0.0648
2024
-0.0287
2025
-0.0159
2026
-0.0121
◌ 2026 = at the latest close (2026-10-22), over the trailing twelve months; earlier years are annual averages · the last point is at the latest close (2026-10-22); earlier quarters use that quarter's average price over the trailing twelve months to it
→Every dollar of market value currently buys -1.2% of annual free cash flow, less than its 5-year median of -3.9% - you are paying up for the same cash.
What this measures
Free cash flow divided by market value: the cash the business generates for every dollar you pay for it. The inverse of a price-to-cash multiple.
What good looks like. A yield at or above the company's own history, and one that compares well with what cash is worth elsewhere.
If it rises or falls. The yield rises when cash grows or the price falls, so a high yield is either a bargain or a warning about the cash continuing. Read it beside the cash conversion chart, which shows whether the cash is holding up.
What does “Value” actually mean?
Value asks what you pay for each dollar of earnings, sales or cash the business produces. A high multiple isn't automatically bad - fast growers earn theirs - but a price far above the company's own history means the market expects a lot to go right. We compare each multiple to the company's own past and to its sector, never to a universal rule.
not profitable: no free cash flow or earnings for the price to rest on
II
Growth
●●●●●●4/6
Growing, with caveats: revenue +52.5% over the last year.
+52.5%vs the year before
+41.8%compound annual
-net income growth
-compound annual
Revenue history
Is RKLB's revenue growing?
◌ amber = the company's own guidance from its earnings release: a forecast, not a reported figure · ◌ dashed quarter = Q4 derived from the annual filing minus Q1, Q2 and Q3 (the SEC never receives a Q4 report)
Period
Revenue ($)
Q3 2020
10.7M
Q1 2021
18.2M
Q2 2021
11.3M
Q3 2021
5.3M
Q4 2021
27.5M
Q1 2022
40.7M
Q2 2022
55.5M
Q3 2022
63.1M
Q4 2022
51.8M
Q1 2023
54.9M
Q2 2023
62.0M
Q3 2023
67.7M
Q4 2023
60.0M
Q1 2024
92.8M
Q2 2024
106.3M
Q3 2024
104.8M
Q4 2024
132.4M
Q1 2025
122.6M
Q2 2025
144.5M
Q3 2025
155.1M
Q4 2025
179.7M
Q1 2026
200.3M
Q2 2026
234.1M
2020
35.2M
2021
62.2M
2022
211.0M
2023
244.6M
2024
436.2M
2025
601.8M
→Revenue reached $602M in 2025, compounding +42% a year since 2022 though the pace has cooled. The trailing twelve months are already running at $769M, ahead of the last full year.
What this measures
The money customers paid, before any costs are taken out. Each bar is one quarter or, on the annual view, a full financial year; the last annual bar may be the trailing twelve months, which the footnote marks.
What good looks like. Growth that repeats, rather than one strong year carrying the chart, and a trailing twelve months keeping pace with the last full year.
If it rises or falls. Revenue is the hardest line to flatter, so a rise is the most trustworthy kind of growth. A fall puts pressure on every margin below it, because costs rarely come down as quickly as sales do.
Revenue by segmentInsight
Where does Rocket Lab's revenue come from?
dashed quarter = Q4 derived from the annual filing minus Q1, Q2 and Q3 (the SEC never receives a Q4 report)
→Rocket Lab makes 81% of its revenue from Space Systems ($189M), and that share has risen from 65% in 2024Q1: the mix is shifting towards Space Systems.
Source: SEC filings - segment disclosures (XBRL notes) · as at 2026-06-30
Profit history
Is RKLB's net profit growing?
◌ dashed quarter = Q4 derived from the annual filing minus Q1, Q2 and Q3 (the SEC never receives a Q4 report)
Period
Net income ($)
Q1 2020
-14.2M
Q2 2020
-9.2M
Q3 2020
-12.6M
Q4 2020
-18.9M
Q1 2021
-15.9M
Q2 2021
-16.7M
Q3 2021
-88.0M
Q4 2021
3.2M
Q1 2022
-26.7M
Q2 2022
-37.4M
Q3 2022
-34.6M
Q4 2022
-37.2M
Q1 2023
-45.6M
Q2 2023
-45.9M
Q3 2023
-40.6M
Q4 2023
-50.5M
Q1 2024
-44.3M
Q2 2024
-41.6M
Q3 2024
-51.9M
Q4 2024
-52.3M
Q1 2025
-60.6M
Q2 2025
-66.4M
Q3 2025
-18.3M
Q4 2025
-52.9M
Q1 2026
-45.0M
Q2 2026
-49.3M
2020
-55.0M
2021
-117.3M
2022
-135.9M
2023
-182.6M
2024
-190.2M
2025
-198.2M
→The company lost $198M in 2025, more than the $190M it lost the year before. The losses are widening - check the Health chapter for how long the cash lasts.
What this measures
What is left after every cost, including tax and interest. The bottom line of the income statement.
What good looks like. Profit growing at least as fast as revenue, which means the business is keeping more of each sale as it gets bigger.
If it rises or falls. Profit can move for reasons revenue cannot explain - a one-off charge, a tax change, a write-down - so a single sharp year is worth checking against the margin chart before reading it as a trend.
Growth rate
How fast are RKLB's revenue and earnings growing?
Year
Revenue growth
Earnings growth
2,021
0.7701
-
2,022
2.3902
-
2,023
0.1592
-
2,024
0.7834
-
2,025
0.3796
-
2026
0.5253
-
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year · on the quarterly views, growth is the trailing twelve months against the twelve before, or a quarter against the same quarter a year earlier
→Revenue grew 53% over the twelve months to 2026-06-30, against an average of +90% a year over 2021-2025.
What this measures
How much revenue and earnings changed against the year before - the trailing twelve months against the twelve before them at each quarter, or one point per fiscal year. It is the speed of the business, not its size.
What good looks like. The earnings line above the revenue line: profits growing faster than sales means each new dollar of sales arrives more profitably than the last.
If it rises or falls. A high growth rate off a small base is easy and gets harder every year, so slowing growth in a large business is normal rather than a warning. Earnings falling while revenue grows is the combination worth understanding: costs are rising faster than sales.
Per-share growth
Are RKLB's revenue and free cash flow per share growing?
Year
Revenue per share ($)
Free cash flow per share ($)
2,020
0.4662
-0.7012
2,021
0.2965
-0.4645
2,022
0.4526
-0.3195
2,023
0.5077
-0.3188
2,024
0.8796
-0.2339
2,025
1.134
-0.6064
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year · each quarterly point is the trailing twelve months to that quarter end, so the last one is the current figure
→Revenue per share reached $1.13 in 2025, compounding +36% a year against +42% for RKLB as a whole. Dilution absorbed about 6.0 points of that growth. The trailing twelve months are running at $1.45 a share. Free cash flow per share stands at $-0.61.
What this measures
Revenue and free cash flow, each divided by the number of shares in issue and adjusted for splits so old and new years compare honestly. Both lines rising means each share owns more of the business's sales and cash.
What good looks like. Both lines rising, and revenue per share growing at least as fast as the company's total revenue, which the answer compares. Faster means buybacks are working for you; slower means new shares are absorbing part of the growth.
If it rises or falls. This is the line that actually reaches you. A company can grow revenue every year and still shrink your slice by issuing shares faster than it grows.
→Rocket Lab had $2.4B of orders not yet delivered at the end of 2026Q2, up from $82M at the end of 2020Q4: demand already signed, ahead of the revenue it becomes.
Source: SEC filings - XBRL financial data · as at 2026-06-30
What does “Growth” actually mean?
Growth here is what the company has actually reported to the SEC - not a forecast. We look at the last year, the three-year pace, whether growth is speeding up or slowing down, and whether it's been consistent rather than one lucky year. Hatched bars are fourth quarters we derived from annual filings (companies file a full-year 10-K rather than a Q4 report).
Profitability is thin or negative. The growth isn't turning into money yet.
37.3%kept after direct costs
-29.1%kept after running costs
-8.8%profit on shareholders' money
-6.1%against a 10% cost of capital
-operating cash ÷ net income
Margins
What profit margin does RKLB keep on each sale?
Year
Gross
Operating
Net
2,020
-0.3361
-1.5629
-1.5644
2,021
-0.0304
-1.6397
-1.8851
2,022
0.09
-0.6408
-0.6443
2,023
0.2102
-0.7274
-0.7464
2,024
0.2663
-0.4351
-0.436
2,025
0.3443
-0.3803
-0.3294
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year · each quarterly point is the trailing twelve months to that quarter end, so the last one is the current figure
→Operating margin widened 26 points to -38% since 2022. The bottom line is still negative: costs below the operating line eat what is left.
What this measures
What survives at three points on the way down the income statement: after the direct cost of the product, after the cost of running the company, and after everything.
What good looks like. Margins that hold or widen as the business grows. The level itself varies enormously by industry, so the shape over time tells you more than the number.
If it rises or falls. A widening margin means pricing power or costs under control. A compressing one means the opposite, and it compounds: on large revenue, two points of margin is a great deal of profit.
Earnings quality
Does RKLB's operating cash flow keep up with its profit?
Year
Cash from operations
Net income
2,020
-27.8M
-55.0M
2,021
-71.8M
-117.3M
2,022
-106.5M
-135.9M
2,023
-98.9M
-182.6M
2,024
-48.9M
-190.2M
2,025
-165.5M
-198.2M
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year · each quarterly point is the trailing twelve months to that quarter end, so the last one is the current figure
→The company generated -$166M of operating cash in 2025. With no profit to compare against, cash generation is the number that matters here.
What this measures
Reported profit against the cash the business actually collected from operating. Profit is an accounting judgement; cash is not.
What good looks like. Cash at or above profit, year after year. Depreciation and other non-cash charges usually push cash above profit, so roughly 100% or more is healthy.
If it rises or falls. Cash falling behind profit for more than a year is the classic early warning: the sales are booked but the money has not arrived, and it shows up in receivables and inventory. For a lender the comparison behaves differently, because a growing loan book consumes cash.
Returns on capital
What return on equity and on capital does RKLB earn?
Year
ROE
ROA
ROCE
2,022
-0.1982
-0.1374
-0.1636
2,023
-0.2974
-0.194
-0.2479
2,024
-0.4059
-0.1606
-0.2247
2,025
-0.1884
-0.0853
-0.115
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year · each quarterly point is the trailing twelve months to that quarter end, so the last one is the current figure
→ROE of -9% and ROCE of -6% sit close together, so the returns come from the business itself rather than from borrowing.
What this measures
Two returns side by side: on shareholders' capital (ROE), and on all the capital in the business including debt (ROCE).
What good looks like. Both comfortably above roughly 10%, and close together. A wide gap means borrowing, not operations, is doing the work.
If it rises or falls. A high ROE built on debt looks like quality until the debt has to be refinanced. ROCE is the harder number to flatter, which is why both are shown.
Income waterfall
Where does RKLB's revenue go, from sales to net profit?
Step
Amount ($)
Revenue, last 12m
769.1M
Gross profit
286.6M
Operating income
-223.5M
Net income
-165.5M
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year
→Of $769M over the twelve months to 2026-06-30 sales, nothing reaches the bottom line - the journey from revenue to profit ends $165M underwater.
What this measures
One year of revenue, with each major cost taken out in the order the income statement takes it, ending at net profit.
What good looks like. No single step swallowing a surprising share, and a bottom line that survives all of them.
If it rises or falls. The largest step is where the business really spends its money, and it is the one to watch year to year: a step that grows faster than revenue is what margin compression looks like before it reaches the margin chart.
Cash conversion
How much of each sale does RKLB turn into free cash flow?
Period
FCF margin
2020
-1.5039
2021
-1.5664
2022
-0.7059
2023
-0.6279
2024
-0.2659
2025
-0.5347
→Free cash flow is negative, so no share of revenue is currently converting to spare cash. Every sales dollar is being reinvested or consumed.
What this measures
Free cash flow as a share of revenue: how much of each dollar of sales survives both costs and capital spending.
What good looks like. A steady or rising share. Asset-light businesses convert far more than manufacturers, so compare a company with itself.
If it rises or falls. Falling conversion while revenue grows means growth is being bought with capital spending or working capital, which is fine while it lasts and painful when it stops.
Spending intensity
How much of its revenue does RKLB spend on capex, R&D and stock pay?
Year
Capex % of rev
R&D % of rev
Stock comp % of rev
2,020
0.7145
0.5444
0.12
2,021
0.4129
0.6711
0.5231
2,022
0.201
0.3089
0.2637
2,023
0.2237
0.4867
0.2186
2,024
0.1538
0.3998
0.1302
2,025
0.2597
0.4498
0.1181
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year · each quarterly point is the trailing twelve months to that quarter end, so the last one is the current figure
→The biggest claim on each sales dollar is research and development, at 45% of revenue (capital spending 26%, stock compensation 12%). That share has risen since 2022, so the cost of competing is climbing.
What this measures
Capital spending, research and development, and stock compensation, each as a share of revenue. The three ways a business pays to keep its position.
What good looks like. A share that is stable or falling while revenue grows, which means the cost of competing is not rising with the business.
If it rises or falls. Rising intensity means each new dollar of sales is getting more expensive to win. Falling intensity can mean efficiency, or it can mean under-investment that shows up years later.
Building NeutronInsight
What makes up Rocket Lab's property and equipment?
→$139M of Rocket Lab's $499M of plant is still being built, 28% of it. Neutron is a rocket that has not flown, and this is the part of the balance sheet that is waiting on it.
Source: SEC filings - segment disclosures (XBRL notes) · as at 2026-06-30
Customer concentrationInsight
How much of Rocket Lab's revenue comes from its largest customers?
→Rocket Lab's largest customer made up 28% of its revenue in FY2025, up from 13% in FY2023.
Source: SEC filings: customer concentration notes (XBRL) · as at 2026-06-30
Return on capital employed
Is RKLB's return on capital above what its capital costs?
Period
Return on capital employed
2020
-0.3941
2021
-0.1154
2022
-0.1636
2023
-0.2479
2024
-0.2247
2025
-0.115
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year · each quarterly point is the trailing twelve months to that quarter end, so the last one is the current figure
→RKLB's return on capital is negative at -11.5% in 2025. The capital in the business is not yet earning anything back.
What this measures
The same return as the card above, but every filed year, against a 10% line that stands in for what capital costs.
What good looks like. Years above the line, and a trend that is flat or rising rather than drifting down towards it.
If it rises or falls. A business earning above its cost of capital creates value by growing; one earning below it destroys value by growing. The 10% line is a convention, not a law, so read the distance from it rather than the crossing.
What does “Quality” actually mean?
Quality asks whether the growth makes real money. Margins show how much of each sale survives costs; return on equity shows what shareholders earn on their capital; and the profit-to-cash comparison catches companies whose accounting profits never turn into actual cash.
TTM operating cash flow -$222M on a net loss of $165M
IV
Financial health
●●●●●●4/6
Financially sound overall, with one or two things worth watching.
0.00xborrowed vs owned
5.5xnear-term bills coverage
-16xearnings ÷ interest bill
$2.3Bcash plus short-term investments
Debt & cash
How much debt does RKLB carry, and do its profits cover the interest?
Year
Total debt
Cash & investments
2,019
-
97.7M
2,020
0
52.8M
2,021
100.1M
691.0M
2,022
102.9M
471.8M
2,023
105.4M
244.8M
2,024
56.1M
419.0M
2,025
1.7M
1.02B
2,026
1.7M
2.30B
◌ each quarterly point is the balance sheet at that quarter end
→The company holds $2.3B in cash against $2M of debt - a net-cash balance sheet, which means a bad year is an inconvenience rather than a threat.
What this measures
Total borrowings against cash on hand, with debt as a multiple of shareholders' equity, and how many times profit covers the interest bill.
What good looks like. Interest covered comfortably - roughly eight times or more - and debt that is not a large multiple of equity.
If it rises or falls. Debt is only a problem when it has to be repaid or refinanced in a bad year, so cover matters more than the amount. Rising debt with rising cover is a business borrowing to grow; rising debt with falling cover is the combination that ends badly.
Near-term liquidity
Do RKLB's current assets cover the bills due within a year?
Period
Current ratio
2020
1.9231
2021
8.0447
2022
4.0646
2023
2.1342
2024
2.04
2025
4.0826
◌ 2026 = the latest balance sheet (2026-06-30), not a fiscal year-end · each quarterly point is the balance sheet at that quarter end
→Near-term liquidity is comfortable: 5.5x of current assets for every dollar due within the year. That is stronger than in 2020.
What this measures
Current assets over current liabilities: what the company can turn into cash within a year against what it owes within a year.
What good looks like. Comfortably above 1.0, and not falling year after year. Below 1.0 means near-term bills exceed near-term resources, which is normal for some business models and a warning in others.
If it rises or falls. Inventory and receivables build it up; short-term borrowing and payables pull it down. A retailer that turns stock over quickly can run lower than a manufacturer and be perfectly sound.
Interest cover
How many times over can RKLB's operating profit pay its interest bill?
Period
Interest cover (x)
2023
-10.1522
2024
-7.2501
2025
-8.639
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year · each quarterly point is the trailing twelve months to that quarter end, so the last one is the current figure
→Operating profit does not cover the interest bill (-15.8x).
What this measures
Operating profit divided by interest expense - how many times over the year's earnings could pay the year's interest.
What good looks like. High and steady. Five times is a common floor; comfortably above it means the debt is being carried, not merely serviced.
If it rises or falls. It falls when profit falls or when borrowing costs rise, and a company can look safe on the level while the direction is telling you otherwise.
Cash conversion
How much of RKLB's revenue arrives as operating cash?
Period
Operating cash flow / revenue
2020
-0.7894
2021
-1.1535
2022
-0.5049
2023
-0.4042
2024
-0.1121
2025
-0.275
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year · each quarterly point is the trailing twelve months to that quarter end, so the last one is the current figure
→RKLB's operations consumed cash rather than produced it over the last twelve months. Up from -78.9% in 2020.
What this measures
Operating cash flow as a share of revenue: of every dollar sold, how much reached the bank before capital spending.
What good looks like. A high share, holding up or improving. It is the clearest sign that reported profit is real.
If it rises or falls. It falls when customers take longer to pay or stock builds up, and it can stay high while profit falls - which is usually the more reassuring of the two.
Shareholders' equity
Is RKLB's shareholder equity (book value) growing?
Period
Equity ($)
2019
-118.5M
2020
-166.7M
2021
698.4M
2022
673.2M
2023
554.5M
2024
382.5M
2025
1.72B
2026
3.49B
→The company's own capital grew from $555M in 2023 to $3.5B (+530%). The business is building book value rather than consuming it.
What this measures
What would be left for shareholders if every asset were sold at its book value and every debt repaid. Book value, in other words.
What good looks like. Equity growing as retained profits build up, unless the company is deliberately returning more than it earns.
If it rises or falls. Equity falls for two very different reasons: buybacks, which return money to you, and losses, which do not. The distinction is the whole story, and negative equity means liabilities now exceed assets, which makes debt-to-equity and return on equity meaningless rather than alarming.
What does “Health” actually mean?
Health asks one question: can the business survive a bad year? We check whether near-term bills are covered, whether debt is modest and shrinking, whether earnings comfortably pay the interest, and - for loss-makers - how many years of cash are left at the current burn rate.
RKLB returns nothing to shareholders yet, and the share count keeps rising. Every dollar stays in the business.
-bought back, TTM, over market value
-at the current rate
-dividends plus buybacks
$82Mlast 12m, dilutes the buybacks
+655.5%since 2020 (split-adjusted)
Share count change (split-adjusted)
Is RKLB's share count rising or falling?
Year
Share-count change
2,021
1.7832
2,022
1.2212
2,023
0.0334
2,024
0.0294
2,025
0.07
→The share count grew 7.0% in 2025, averaging 4.4% a year over three years. Your slice of the company shrinks by that much each year unless earnings grow faster.
What this measures
The yearly change in the number of shares in issue, adjusted for splits so the years compare. A bar below zero is a falling share count, usually from buybacks; above zero, new shares were issued.
What good looks like. A flat or falling share count. Falling means each share you hold owns a little more of the business every year.
If it rises or falls. A rising count divides the same business among more owners, so your slice shrinks unless profits grow faster. This is the most direct chart on the page: it is your ownership, measured.
Dilution against what it bought
Has RKLB's revenue per share grown faster than its share count?
Change since 2020. The gap between the lines is what each share gained or lost. Share counts are split-adjusted weighted averages.
Year
Share count, change since 2020
Revenue per share, change since 2020
2,020
0
0
2,021
1.7832
-0.364
2,022
5.182
-0.0293
2,023
5.3882
0.089
2,024
5.576
0.8866
2,025
6.0366
1.4324
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year · on the quarterly view, revenue per share is the trailing twelve months over that quarter's diluted count
→RKLB's share count rose 604% from 2020 to 2025 while revenue per share grew 143%. Holders are further ahead than before, though the gain per share is smaller than the growth in the business.
What this measures
The share count and revenue per share over the same years, both indexed to 100 at the start, so the two lines can be compared directly.
What good looks like. The per-share line above the share-count line: whatever the company did with its shares, more business ended up behind each one.
If it rises or falls. Issuing shares is not automatically bad. It is bad when the money raised buys less growth than the dilution cost, which is exactly what the gap between these two lines shows.
Why compare buybacks with stock compensation?
A company can trumpet billions in buybacks while quietly issuing nearly as much stock to employees. What matters to you is the net effect: is the share count actually falling? If not, the 'return' is mostly recycling.
→RKLB is in a downtrend: the price is below the cloud where recent trading settled and that cloud is still falling. Both shorter readings point down as well, so nothing here disagrees with the downtrend.
How the trend above is worked out
The trend read is the daily Ichimoku picture, the same indicator drawn on the chart above. Five names, and what each one is: the TENKAN is the midpoint of the last 9 sessions' high and low, the fast line; the KIJUN is the same over 26 sessions, the slow one; the two SENKOU spans are midpoints drawn 26 sessions into the FUTURE, and the band between them is the KUMO cloud - because it is drawn forward, the support for the coming weeks is already fixed and a change of its direction can be seen coming; the CHIKOU is today's close compared with the close 26 sessions back. A trend confirms itself in that order and the checks follow it: price clears the cloud, holds above both lines, the Tenkan crosses above the Kijun, the cloud ahead turns up, and the Chikou stands higher than the price a month ago. Six of six therefore means all of that at once; a price sitting inside the cloud, or below its own lines, cannot get there. The last check is the one Ichimoku cannot answer - whether the S&P 500 did better over 12 months (252 sessions), measured on the SPY ETF with dividends included, on the same adjusted basis as the stock's own price. Our figures are the last close we hold, refreshed every trading night; the chart is live. None of this says anything about the business, and it is not advice.
Are RKLB's insiders buying or selling shares with their own money?
Month
Buys ($)
Sells ($)
2023-11
0
344,383
2023-12
0
0
2024-01
0
0
2024-02
0
0
2024-03
0
419,150
2024-04
0
0
2024-05
0
390,304
2024-06
0
0
2024-07
0
0
2024-08
0
906,059
2024-09
0
0
2024-10
0
0
2024-11
0
102.1M
2024-12
0
2.6M
2025-01
0
0
2025-02
0
0
2025-03
0
2.6M
2025-04
0
0
2025-05
0
3.9M
2025-06
0
27.4M
2025-07
0
0
2025-08
0
0
2025-09
0
267.5M
2025-10
0
0
2025-11
0
9.5M
2025-12
0
146.2M
2026-01
0
121.2M
2026-02
0
0
2026-03
0
16.5M
2026-04
0
0
2026-05
0
62.0M
2026-06
0
14.4M
2026-07
0
286.4M
2026-08
0
8.3M
2026-09
0
8.8M
2026-10
0
9.9M
→Since November 2023, insiders sold $1.1B on the open market and bought nothing. Many sales are pre-scheduled diversification rather than a view on the price. A further 78 transactions were grants, option exercises or tax withholding, which say nothing either way.
What this measures
Open-market buys and sells by the company's own officers and directors, from their Form 4 filings. Grants, option exercises and shares withheld for tax are excluded, because they are compensation rather than decisions.
What good looks like. Buying with their own money, which is the one insider action that is hard to explain away.
If it rises or falls. Selling is weak evidence: insiders sell to diversify, to buy houses, and on pre-scheduled plans set months ahead. Buying is stronger evidence, because there is only one reason to do it. The absence of any buying over a long stretch is itself worth noticing.
The record
Who did what, exactly?
Date
Insider
Role
Type
Shares
Price
Value
2026-10-01
Adam C. Spice
Chief Financial Officer
exercise
140,157
$1.09
$152,771
2026-10-01
Adam C. Spice
Chief Financial Officer
SELL
39,669
$70.28
$2.79M
2026-10-01
Adam C. Spice
Chief Financial Officer
SELL
85,288
$70.89
$6.05M
2026-10-01
Adam C. Spice
Chief Financial Officer
SELL
15,200
$71.79
$1.09M
2026-09-02
Adam C. Spice
Chief Financial Officer
exercise
140,157
$1.09
$152,771
2026-09-02
Adam C. Spice
Chief Financial Officer
SELL
67,257
$62.26
$4.19M
2026-09-02
Adam C. Spice
Chief Financial Officer
SELL
72,900
$62.97
$4.59M
2026-08-27
Frank Klein
Chief Operations Officer
SELL
15,300
$66.25
$1.01M
2026-08-27
Frank Klein
Chief Operations Officer
SELL
19,800
$66.86
$1.32M
2026-08-27
Frank Klein
Chief Operations Officer
SELL
458
$67.54
$30,933
2026-08-27
Arjun Kampani
SVP & General Counsel
SELL
4,600
$66.50
$305,882
2026-08-27
Arjun Kampani
SVP & General Counsel
SELL
1,434
$67.16
$96,304
2026-08-24
Adam C. Spice
Chief Financial Officer
SELL
8,952
$69.53
$622,473
2026-08-24
Adam C. Spice
Chief Financial Officer
SELL
290
$70.20
$20,359
2026-08-24
Adam C. Spice
Chief Financial Officer
SELL
435
$71.17
$30,959
2026-08-24
Agostino Ricupati
VP Corp Controller & CAO
SELL
619
$69.53
$43,042
2026-08-24
Agostino Ricupati
VP Corp Controller & CAO
SELL
20
$70.20
$1,404
2026-08-24
Agostino Ricupati
VP Corp Controller & CAO
SELL
30
$71.17
$2,135
2026-08-24
Frank Klein
Chief Operations Officer
SELL
42,270
$69.53
$2.94M
2026-08-24
Frank Klein
Chief Operations Officer
SELL
1,368
$70.20
$96,037
2026-08-24
Frank Klein
Chief Operations Officer
SELL
2,054
$71.17
$146,183
2026-08-24
Arjun Kampani
SVP & General Counsel
SELL
7,173
$69.53
$498,771
2026-08-24
Arjun Kampani
SVP & General Counsel
SELL
232
$70.20
$16,287
2026-08-24
Arjun Kampani
SVP & General Counsel
SELL
349
$71.17
$24,838
2026-08-24
Marvin Bradford Clevenger
President, Rocket Lab USA, Inc
SELL
13,924
$69.53
$968,198
2026-08-24
Marvin Bradford Clevenger
President, Rocket Lab USA, Inc
SELL
450
$70.20
$31,591
2026-08-24
Marvin Bradford Clevenger
President, Rocket Lab USA, Inc
SELL
677
$71.17
$48,182
2026-07-08
Peter Beck
CEO
SELL
265,958
$81.59
$21.7M
2026-07-08
Peter Beck
CEO
SELL
354,128
$82.48
$29.21M
2026-07-08
Peter Beck
CEO
SELL
156,666
$83.33
$13.05M
2026-07-08
Peter Beck
CEO
SELL
142,390
$84.43
$12.02M
2026-07-08
Peter Beck
CEO
SELL
67,773
$85.30
$5.78M
2026-07-08
Peter Beck
CEO
SELL
4,045
$86.12
$348,360
2026-07-07
Peter Beck
CEO
SELL
342,190
$83.58
$28.6M
2026-07-07
Peter Beck
CEO
SELL
458,494
$84.31
$38.65M
2026-07-07
Peter Beck
CEO
SELL
257,803
$85.33
$22M
2026-07-07
Peter Beck
CEO
SELL
88,548
$86.12
$7.63M
2026-07-07
Peter Beck
CEO
SELL
41,554
$87.31
$3.63M
2026-07-07
Peter Beck
CEO
SELL
74,874
$88.40
$6.62M
2026-07-07
Peter Beck
CEO
SELL
20,593
$89.37
$1.84M
2026-07-07
Peter Beck
CEO
SELL
14,566
$90.26
$1.31M
2026-07-06
Peter Beck
CEO
SELL
213,106
$92.81
$19.78M
2026-07-06
Peter Beck
CEO
SELL
198,726
$93.74
$18.63M
2026-07-06
Peter Beck
CEO
SELL
84,387
$94.69
$7.99M
2026-07-06
Peter Beck
CEO
SELL
138,478
$95.89
$13.28M
2026-07-06
Peter Beck
CEO
SELL
169,457
$96.78
$16.4M
2026-07-06
Peter Beck
CEO
SELL
77,684
$97.70
$7.59M
2026-07-06
Peter Beck
CEO
SELL
76,178
$98.70
$7.52M
2026-07-06
Peter Beck
CEO
SELL
8,202
$99.62
$817,046
2026-07-06
Peter Beck
CEO
SELL
14,266
$100.53
$1.43M
2026-07-06
Peter Beck
CEO
SELL
5,713
$101.57
$580,268
2026-06-18
Arjun Kampani
SVP & General Counsel
SELL
88,000
$107.98
$9.5M
2026-06-02
Alexander R Slusky
Director
SELL
40,000
$123.60
$4.94M
Why do the transaction types matter so much?
Most insider filings are not trades: stock grants, option exercises and tax withholding are how executives get paid, and gifts are estate planning. The signal lives in open-market transactions - a buy means an insider chose to spend their own cash on the stock. Sells are murkier: many are pre-scheduled 10b5-1 plans set months in advance. That's why the chart counts only open-market activity, and the table labels every row.
VIII
Ownership
informational
53.8%on Form 13F, 30 June 2026
10.3%officers, directors, founders
35.9%together
1of the 18 TenQ follows
Top holders
Who owns Rocket Lab stock?
Fund managers filing Form 13F held 53.8% of the company's shares on 30 June 2026. The largest holder is BlackRock, Inc., with 6.8%. Insiders hold 10.3%.
#
Holder
Stake
Shares
Value
Change
1
BlackRock, Inc.Fund manager
6.78%
40.6M
$2.1B
+6.8%
2
Khosla Ventures Seed B, L.P.10% owner · Form 4, 26 August 2024
6.32%
37.8M
$1.9B
-
3
Vanguard Portfolio Management LLCFund manager
4.53%
27.1M
$1.4B
+5.4%
4
Vanguard Capital Management LLCFund manager
4.23%
25.3M
$1.3B
+4.2%
5
Invesco Ltd.Fund manager
3.07%
18.3M
$940M
+409.8%
6
Khosla Ventures V, L.P.10% owner · Form 4, 23 July 2025
2.73%
16.3M
$836M
-
7
State Street CorpFund manager
2.41%
14.4M
$740M
+3.7%
8
JPMorgan Chase & CoFund manager
2.31%
13.8M
$707M
+29.3%
9
Geode Capital Management, LLCFund manager
1.76%
10.5M
$538M
-0.6%
10
Baillie Gifford & CoFund manager
1.74%
10.4M
$532M
-43.6%
11
Capital World InvestorsFund manager
1.23%
7.4M
$378M
+1.8%
12
Morgan StanleyFund manager
1.15%
6.9M
$353M
+28.1%
13
Goldman Sachs Group IncFund manager
0.93%
5.6M
$285M
+117.5%
14
Norges BankFund manager
0.91%
5.4M
$278M
New
15
Bank of America CorpFund manager
0.72%
4.3M
$220M
-5.1%
16
FMR LLCFund manager
0.62%
3.7M
$190M
+0.2%
17
UBS Group AGFund manager
0.60%
3.6M
$185M
+73.5%
18
Vanguard Fiduciary Trust CoFund manager
0.56%
3.4M
$172M
+9.3%
19
Northern Trust CorpFund manager
0.55%
3.3M
$170M
+7.2%
20
Charles Schwab Investment Management IncFund manager
0.47%
2.8M
$145M
+20.3%
The full list of top holders is free with an account
Source: SEC Form 13F filings for the quarter to 30 June 2026, Schedules 13D and 13G, and Form 4. Shares on today's basis, value at the latest price.
Super investors
Which super investors own Rocket Lab stock?
Cathie Wood's ARK Investment Management holds Rocket Lab, 1.1% of its portfolio, as of 30 June 2026. It is the only one of the 18 super investors TenQ follows that holds it.
Source: each firm's Form 13F for the quarter to 30 June 2026, and its Form 4 and Schedules 13D and 13G since. A weight is the holding's share of the firm's 13F portfolio. All super investors
Where does this list come from?
Fund managers with more than $100 million in US stocks report their holdings every quarter on Form 13F, up to 45 days after the quarter ends, so the fund figures are as of the last quarter end. A fund family reports as one manager, and funds together can report more than 100%: shares lent to short sellers are bought again by other funds, and both report them. Anyone holding more than 5% of a class files a Schedule 13D or 13G, and officers and directors report what they hold on Form 4 after every trade, so those rows carry their own dates. Short positions are not reported anywhere. A stake is the holder's shares as a share of all the company's shares, with other share classes converted at their market value.